Molecular diagnostics are well-established in clinical medicine. Nonetheless, the markets for these tests remain one of the most attractive growth opportunities in the in vitro diagnostics industry.
Administrative Aspects of Molecular Diagnostics—Oversight, Regulatory Approval Process, Clinical and Operational Workflows, and Payment Models. If you have the appropriate software installed, you can ...
Oliver Bathe walks through addressing the surge in papillary thyroid cancer incidence by refining cancer care through ...
Molecular diagnostic (MDx) tests should provide results quickly and reliably. By choosing instruments, reagents, software, services, and support offerings that exist in a single MDx ecosystem, ...
Clinical Utility of Pharmacogenomics and Genetic Testing Remains an Issue Through rapid advances in research and clinical applications, molecular diagnostics has grown from a genomic and proteomic ...
Renal tumor pathology has evolved considerably, expanding from two main types of renal malignant tumors to over 20 distinct types. Diagnostic criteria have advanced from purely morphological features ...
REDMOND, Wash.--(BUSINESS WIRE)--Anavasi Diagnostics, an NIH/RADx funded medical technology company developing novel molecular diagnostic testing for the point-of-care (POC) market, announced the Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback